Ubs Asset Management Americas Inc Merus N.V. Transaction History
Ubs Asset Management Americas Inc
- $379 Billion
- Q1 2025
A detailed history of Ubs Asset Management Americas Inc transactions in Merus N.V. stock. As of the latest transaction made, Ubs Asset Management Americas Inc holds 112,522 shares of MRUS stock, worth $5.63 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
112,522
Previous 98,744
13.95%
Holding current value
$5.63 Million
Previous $4.15 Million
14.07%
% of portfolio
0.0%
Previous 0.0%
Shares
11 transactions
Others Institutions Holding MRUS
# of Institutions
195Shares Held
62.2MCall Options Held
355KPut Options Held
96.5K-
Wellington Management Group LLP Boston, MA4.72MShares$236 Million0.04% of portfolio
-
Commodore Capital LP New York, NY4.47MShares$224 Million18.43% of portfolio
-
Rtw Investments, LP New York, NY4.17MShares$209 Million2.88% of portfolio
-
Paradigm Biocapital Advisors LP New York, NY3.37MShares$169 Million7.27% of portfolio
-
Deerfield Management Company, L.P. (Series C) New York, NY3.17MShares$159 Million3.38% of portfolio
About Merus N.V.
- Ticker MRUS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 45,878,200
- Market Cap $2.29B
- Description
- Merus N.V., a clinical-stage immuno-oncology company, engages in the discovery and development of bispecific antibody therapeutics in the Netherlands. Its bispecific antibody candidate pipeline includes Zenocutuzumab (MCLA-128), which is in a phase 2 clinical trials for the treatment of patients with metastatic breast cancer, as well as in Phase...